Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
about
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeIntestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus InfectionSustaining Vaccine Confidence in the 21st CenturyImmunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in porcine intestinal epithelial and antigen presenting cells.Novel porcine-like human G26P[19] rotavirus identified in hospitalized paediatric diarrhoea patients in Ho Chi Minh City, Vietnam.Genotyping and clinical factors in pediatric diarrhea caused by rotaviruses: one-year surveillance in Surabaya, Indonesia.Evaluation of Luminex xTAG Gastrointestinal Pathogen Panel Assay for Detection of Multiple Diarrheal Pathogens in Fecal Samples in Vietnam.Budget constraint and vaccine dosing: a mathematical modelling exercise.Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study.Relevance of secretor status genotype and microbiota composition in susceptibility to rotavirus and norovirus infections in humansGene therapy as a vaccine for HIV-1.Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas.Challenges and impact of conducting vaccine trials in Asia and Africa: New Technologies in Emerging Markets, October 16th-18th 2012; World Vaccine Congress, Lyon.Waging war against rotavirus at home and abroad.
P2860
Q27004488-5B3328FE-2F50-4797-8078-A8D2DC8D2D5BQ28074046-83809A87-4806-441A-9636-1921A7CE2A75Q28647427-FB25A9CD-F6EA-474F-91D1-BFF47AEF32D4Q33673989-1E5707A0-E08D-4E82-961B-123D6D31EF43Q34520585-7DE923AD-E182-4FA3-8D70-CECCA4C0E594Q35194810-B107EF32-D782-496D-962D-FACDCF6C3AD0Q36734961-1B5E3778-3549-4094-A366-1354581B78EDQ37522192-25E49367-7914-4C5C-8E23-31E50E1CE8BFQ37728321-A8B06876-6FED-4D02-9272-8C14850627ABQ37728352-59FB59CE-9016-4C48-8C96-F07630BD0BA7Q38026862-9A012A88-E27D-4C39-B402-99CC67A1272BQ38068232-ECC9A0A3-2497-4744-9CE3-C430C14844CEQ41632202-83BAD171-BFE5-4BB9-BEB6-D3E8352E18DCQ42733082-441905FE-2BC7-45A6-89CC-223F92B7840EQ43204167-3AD6D754-6E14-4C2F-B013-BD22486DEEE7
P2860
Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Remaining issues and challenge ...... rheal morbidity and mortality.
@en
Remaining issues and challenge ...... rheal morbidity and mortality.
@nl
type
label
Remaining issues and challenge ...... rheal morbidity and mortality.
@en
Remaining issues and challenge ...... rheal morbidity and mortality.
@nl
prefLabel
Remaining issues and challenge ...... rheal morbidity and mortality.
@en
Remaining issues and challenge ...... rheal morbidity and mortality.
@nl
P2093
P2860
P50
P356
P1476
Remaining issues and challenge ...... rheal morbidity and mortality.
@en
P2093
A Duncan Steele
Jessica Fleming
Jon R Gentsch
Manish M Patel
Margaret M Cortese
P2860
P304
P356
10.1586/ERV.11.184
P577
2012-02-01T00:00:00Z